NASDAQ •
Healthcare •
Diagnostics & Research •
Quote as of 07/28/2026 16:00
Company Profile
IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,238.43 mln
Float329 mln
Earnings Date07/27/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
-2.88
Likely reliable
1-Year Forecast
4.38
Transformational upside
Relative Strength
99
/ 100
Top performer
Debt / Equity
0.34
Low leverage
ROE
-5.82
Negative
Business Description
OPKO Health is a global healthcare company founded in 2006 and based in Miami, Florida, with operations across the United States, Europe, Latin America, and Israel. The company develops a range of medical treatments, including experimental cancer-fighting antibodies, a hormone supplement for oral use, a drug designed to control blood sugar and body weight, and a long-acting growth hormone therapy for children. Through its BioReference laboratory brand, OPKO also provides a broad set of diagnostic testing services, covering areas such as genetics, women's health, cancer pathology, and disease monitoring.
